skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 251  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Breast Cancer remove subject: Medicine remove subject: Prognosis remove Original Article remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
Material Type:
Article
Add to My Research

The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status

Breast cancer (Tokyo, Japan), 2022-03, Vol.29 (2), p.234 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-021-01303-3 ;PMID: 34622383

Digital Resources/Online E-Resources

2
Candidate miRNAs in human breast cancer biomarkers: a systematic review
Material Type:
Article
Add to My Research

Candidate miRNAs in human breast cancer biomarkers: a systematic review

Breast cancer (Tokyo, Japan), 2018-03, Vol.25 (2), p.198 [Peer Reviewed Journal]

EISSN: 1880-4233 ;DOI: 10.1007/s12282-017-0814-8 ;PMID: 29101635

Digital Resources/Online E-Resources

3
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
Material Type:
Article
Add to My Research

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

Breast cancer (Tokyo, Japan), 2022-09, Vol.29 (5), p.844-853 [Peer Reviewed Journal]

The Author(s) 2022 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-022-01364-y

Digital Resources/Online E-Resources

4
lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer
Material Type:
Article
Add to My Research

lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer

Breast cancer (Tokyo, Japan), 2020-07, Vol.27 (4), p.573 [Peer Reviewed Journal]

EISSN: 1880-4233 ;DOI: 10.1007/s12282-020-01048-5 ;PMID: 31960363

Digital Resources/Online E-Resources

5
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
Material Type:
Article
Add to My Research

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer

Breast cancer (Tokyo, Japan), 2021-07, Vol.28 (4), p.904-914 [Peer Reviewed Journal]

The Author(s) 2021 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-021-01227-y ;PMID: 33629216

Digital Resources/Online E-Resources

6
Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer
Material Type:
Article
Add to My Research

Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer

Breast cancer (Tokyo, Japan), 2022-07, Vol.29 (4), p.666-676 [Peer Reviewed Journal]

The Author(s) 2022 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-022-01344-2

Digital Resources/Online E-Resources

7
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study
Material Type:
Article
Add to My Research

High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study

Breast cancer (Tokyo, Japan), 2020-07, Vol.27 (4), p.706-715 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-020-01067-2 ;PMID: 32133606

Digital Resources/Online E-Resources

8
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration
Material Type:
Article
Add to My Research

Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration

Breast cancer (Tokyo, Japan), 2023-09, Vol.30 (5), p.748 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01467-0 ;PMID: 37178415

Digital Resources/Online E-Resources

9
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB
Material Type:
Article
Add to My Research

Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB

Breast cancer (Tokyo, Japan), 2024-05, Vol.31 (3), p.426 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-024-01554-w ;PMID: 38472737

Digital Resources/Online E-Resources

10
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC
Material Type:
Article
Add to My Research

HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC

Breast cancer (Tokyo, Japan), 2023-05, Vol.30 (3), p.364 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-022-01431-4 ;PMID: 36656510

Digital Resources/Online E-Resources

11
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience
Material Type:
Article
Add to My Research

The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience

Breast cancer (Tokyo, Japan), 2024-03, Vol.31 (2), p.252-262 [Peer Reviewed Journal]

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01530-w ;PMID: 38150135

Digital Resources/Online E-Resources

12
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR-/HER2+ breast cancer subtypes
Material Type:
Article
Add to My Research

Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR-/HER2+ breast cancer subtypes

Breast cancer (Tokyo, Japan), 2024-03, Vol.31 (2), p.295 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01538-2 ;PMID: 38231460

Digital Resources/Online E-Resources

13
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database
Material Type:
Article
Add to My Research

Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database

Breast cancer (Tokyo, Japan), 2024-03, Vol.31 (2), p.205 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01523-9 ;PMID: 38043116

Digital Resources/Online E-Resources

14
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers
Material Type:
Article
Add to My Research

An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers

Breast cancer (Tokyo, Japan), 2023-09, Vol.30 (5), p.703-713 [Peer Reviewed Journal]

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01462-5 ;PMID: 37115435

Digital Resources/Online E-Resources

15
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)
Material Type:
Article
Add to My Research

Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)

Breast cancer (Tokyo, Japan), 2023-05, Vol.30 (3), p.412 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01436-7 ;PMID: 36689066

Digital Resources/Online E-Resources

16
Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence
Material Type:
Article
Add to My Research

Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence

Breast cancer (Tokyo, Japan), 2020-01, Vol.27 (1), p.54 [Peer Reviewed Journal]

EISSN: 1880-4233 ;DOI: 10.1007/s12282-019-00994-z ;PMID: 31280452

Digital Resources/Online E-Resources

17
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
Material Type:
Article
Add to My Research

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro

Breast cancer (Tokyo, Japan), 2023-09, Vol.30 (5), p.758-771 [Peer Reviewed Journal]

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01470-5 ;PMID: 37199905

Digital Resources/Online E-Resources

18
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population
Material Type:
Article
Add to My Research

Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population

Breast cancer (Tokyo, Japan), 2023-09, Vol.30 (5), p.739 [Peer Reviewed Journal]

2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-023-01466-1 ;PMID: 37261705

Digital Resources/Online E-Resources

19
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis
Material Type:
Article
Add to My Research

Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis

Breast cancer (Tokyo, Japan), 2022-03, Vol.29 (2), p.314 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-021-01312-2 ;PMID: 34766244

Digital Resources/Online E-Resources

20
Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan
Material Type:
Article
Add to My Research

Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan

Breast cancer (Tokyo, Japan), 2023-03, Vol.30 (2), p.302 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to The Japanese Breast Cancer Society. ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-022-01421-6 ;PMID: 36527601

Digital Resources/Online E-Resources

Results 1 - 20 of 251  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2010  (14)
  2. 2010 To 2012  (23)
  3. 2013 To 2015  (59)
  4. 2016 To 2019  (76)
  5. After 2019  (80)
  6. More options open sub menu

Searching Remote Databases, Please Wait